Fluticasone Furoate

CAS 397864-44-7 16 current recordsSmall Molecule

Who holds supplier records for Fluticasone Furoate? 16 organisations hold a current record for Fluticasone Furoate: an active US FDA Type II Drug Master File or a CEP. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (3), China (1), Netherlands (1) and 2 other countries (2); not recorded for 4.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Fluticasone Furoate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fluticasone-furoate

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Fluticasone Furoate expires 11 Apr 2031. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Fluticasone Furoate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • CORAL DRUGS PVT LTD
    Active DMF 32040, 36316 · latest filing Oct 2021
    IndiaCEP Company GMP cert on record
  • AARTI PHARMALABS LIMITED
    Active DMF 33955 · latest filing Jul 2020
    IndiaCEP
  • Aurisco Pharmaceutical Co.,ltd
    Active DMF 33636 · latest filing Mar 2019
    ChinaCEP Company GMP cert on record
  • Farmabios S.p.A.
    Active DMF 40090 · latest filing Jun 2024
    ItalyCEP Company GMP cert on record
  • NEWCHEM SPA
    Active DMF 41935 · latest filing Jun 2025
    ItalyCEP Company GMP cert on record
  • STERLING SPA
    Active DMF 24647 · latest filing Feb 2011
    ItalyCEP Company GMP cert on record
  • TAPI NL BV
    Active DMF 36621 · latest filing Dec 2023
    NetherlandsCEP
  • BREATHGREEN PHARMACEUTICAL CO LTD
    Active DMF 40975 · latest filing Dec 2024
  • Cipla Limited
    Active DMF 36736 · latest filing Feb 2022
    India Company GMP cert on record
  • GLAXOSMITHKLINE LLC
    Active DMF 31938 · latest filing Sept 2017
  • Lupin Limited
    Active DMF 37465 · latest filing Nov 2022
    India Company GMP cert on record
  • SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD
    Active DMF 44076 · latest filing Apr 2026
  • WAVELENGTH ENTERPRISES LTD
    Active DMF 28554 · latest filing Sept 2014
    Israel Company GMP cert on record
  • PortugalCEP Company GMP cert on record
  • SHANDONG SIRUI PHARMACEUTICAL CO LTD
    CEP
  • VAMSI LABS LTD
    Inactive DMF 40418 · latest filing Aug 2024
    IndiaCEP Company GMP cert on record
Need Fluticasone Furoate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Fluticasone Furoate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
NEWCHEM S.p.A. MilanIT
CEP 2025-094 - Rev 00
Fluticasone furoate, Micronised
Nov 2026—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2024-270 - Rev 00
Fluticasone furoate
Jul 2026Inspected Jul 2026
Italy
VAMSI LABS LIMITED SolapurIN
CEP 2024-298 - Rev 01
Fluticasone furoate, Micronised
Jul 2026—
STERLING S.p.A. CorcianoIT
CEP 2024-345 - Rev 00
Fluticasone furoate
Jun 2026Inspected Dec 2025
Italy
TAPI NL B.V. AmsterdamNL
CEP 2022-015 - Rev 03
Fluticasone furoate
Jun 2026—
SHANDONG SIRUI PHARMACEUTICAL CO., LTD. HezeCN
CEP 2025-315 - Rev 00
Fluticasone furoate
Jan 2026—
AURISCO PHARMACEUTICAL CO., LTD. TiantaiCN
CEP 2022-238 - Rev 01
Fluticasone furoate, Micronised
Dec 2025Inspected Dec 2023
Germany
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
CEP 2024-361 - Rev 00
Fluticasone furoate, Micronised
Dec 2025—
HOVIONE FARMACIENCIA S.A. LouresPT
CEP 2024-146 - Rev 00
Fluticasone furoate, Process I
Jul 2025Inspected Apr 2025
Portugal
CORAL DRUGS PRIVATE LIMITED New DelhiIN
R0-CEP 2021-372 - Rev 00
Fluticasone furoate, Process 1
Mar 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (4 listed products contain Fluticasone Furoate). The latest listed patent expires 11 Apr 2031. The latest listed exclusivity ended 1 Mar 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Fluticasone Furoate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1676).

Chemical identity

IUPAC name
[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
Canonical SMILES
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F
InChIKey
XTULMSXFIHGYFS-VLSRWLAYSA-N
Synonyms
Alisade, Allermist, Arnuity ellipta, Avamys, Ennhale, Flonase sensimist allergy relief, Fluticasone furoate, Fluticasone furoate component of arnuity ellipta, Fluticasone furoate component of breo ellipta, Fluticasone furoate component of trelegy ellipta, Furamist, Furoate de fluticasone

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Fluticasone Furoate?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Fluticasone Furoate: CORAL DRUGS PVT LTD (India), AARTI PHARMALABS LIMITED (India), Aurisco Pharmaceutical Co.,ltd (China), Farmabios S.p.A. (Italy), NEWCHEM SPA (Italy), STERLING SPA (Italy), TAPI NL BV (Netherlands) and BREATHGREEN PHARMACEUTICAL CO LTD, and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Fluticasone Furoate Drug Master Files are active?

CORAL DRUGS PVT LTD (DMF 32040, 36316), AARTI PHARMALABS LIMITED (DMF 33955), Aurisco Pharmaceutical Co.,ltd (DMF 33636), Farmabios S.p.A. (DMF 40090), NEWCHEM SPA (DMF 41935), STERLING SPA (DMF 24647), TAPI NL BV (DMF 36621) and BREATHGREEN PHARMACEUTICAL CO LTD (DMF 40975) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Fluticasone Furoate have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Fluticasone Furoate on the EDQM register, including NEWCHEM S.p.A. Milan (IT), FARMABIOS S.p.A Gropello Cairoli (IT), VAMSI LABS LIMITED Solapur (IN), STERLING S.p.A. Corciano (IT), TAPI NL B.V. Amsterdam (NL) and SHANDONG SIRUI PHARMACEUTICAL CO., LTD. Heze (CN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Fluticasone Furoate?

Yes. The latest patent listed for an approved US product containing Fluticasone Furoate expires 11 Apr 2031, across 4 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Fluticasone Furoate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Fluticasone Furoate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.